Who owns TSCAN THERAPEUTICS INC?
- Ticker: TCRX
- CUSIP Number: 89854m101
Tip: Access positions for across all investors
Analyze quarterly positions in Tscan Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Tscan Therapeutics stock
Who bought or sold TSCAN THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Lynx1 Capital Management | 7.9M | $14M | 0% | Sep 2025 |
|
| BVF | 5.2M | $9.5M | 0% | Sep 2025 |
|
| Baker Bros. Advisors | 2.8M | $5.1M | 0% | Sep 2025 |
|
| BlackRock | 2.4M | $4.3M | -7% | Sep 2025 |
|
| Vanguard Group | 2.3M | $4.2M | 8% | Sep 2025 |
|
| Propel Bio Management | 1.9M | $3.5M | -7% | Sep 2025 |
|
| Standard Life Aberdeen | 1.4M | $2.5M | 52% | Sep 2025 |
|
| Deer Management | 1.2M | $2.3M | 0% | Sep 2025 |
|
| Alphabet | 1.1M | $2.0M | 0% | Sep 2025 |
|
| Simplify Asset Management | 905k | $1.6M | -14% | Sep 2025 |
|
| Morgan Stanley | 853k | $1.2M | 100% | Jun 2025 |
|
| Renaissance Technologies | 830k | $1.5M | 5% | Sep 2025 |
|
| DC Funds | 630k | $1.1B | 0% | Sep 2025 |
|
| Tang Capital Management | 600k | $1.1M | 0% | Sep 2025 |
|
| Geode Capital Management | 568k | $1.0M | 0% | Sep 2025 |
|
| Millennium Management | 466k | $848k | -26% | Sep 2025 |
|
| Two Sigma Investments | 419k | $763k | 15% | Sep 2025 |
|
| Citadel Advisors | 391k | $711k | 78% | Sep 2025 |
|
| Two Sigma Advisers | 289k | $526k | 35% | Sep 2025 |
|
| Jpmorgan Chase & Co | 238k | $433k | -10% | Sep 2025 |
|
| State Street Corporation | 197k | $359k | -2% | Sep 2025 |
|
| Brown Brothers Harriman & Co. | 143k | $260k | 0% | Sep 2025 |
|
| Bridgeway Capital Management | 140k | $256k | -9% | Sep 2025 |
|
| Goldman Sachs Group | 131k | $238k | -23% | Sep 2025 |
|
| Militia Capital Partners | 102k | $186k | 8% | Sep 2025 |
|
| Northern Trust | 99k | $179k | 0% | Sep 2025 |
|
| Stifel Financial | 97k | $177k | -16% | Sep 2025 |
|
| Letko, Brosseau & Associates | 96k | $175k | 0% | Sep 2025 |
|
| NewEdge Wealth | 92k | $104k | 0% | Sep 2025 |
|
| Dimensional Fund Advisors | 87k | $159k | -33% | Sep 2025 |
|
| Jane Street | 81k | $148k | -62% | Sep 2025 |
|
| Susquehanna International | 80k | $145k | -45% | Sep 2025 |
|
| Virtu Financial | 61k | $110k | 431% | Sep 2025 |
|
| Voleon Capital Management | 48k | $87k | 100% | Sep 2025 |
|
| Marshall Wace | 47k | $85k | -13% | Sep 2025 |
|
| Cubist Systematic Strategies | 42k | $77k | -76% | Sep 2025 |
|
| Dean Capital Investments Management | 36k | $65k | 0% | Sep 2025 |
|
| Catalyst Funds Management Pty | 31k | $56k | 71% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 30k | $54k | 26% | Sep 2025 |
|
| Algert Coldiron Investors | 28k | $51k | 0% | Sep 2025 |
|
| Qube Research & Technologies | 28k | $50k | -59% | Sep 2025 |
|
| Hsbc Holdings | 25k | $44k | -19% | Sep 2025 |
|
| LPL Financial | 22k | $39k | 100% | Sep 2025 |
|
| JustInvest | 21k | $38k | 6% | Sep 2025 |
|
| Barclays | 19k | $35k | -10% | Sep 2025 |
|
| R Squared | 19k | $34k | 68% | Sep 2025 |
|
| Neuberger Berman Group | 18k | $34k | -13% | Sep 2025 |
|
| XTX Topco | 18k | $32k | 100% | Sep 2025 |
|
| Mariner Wealth Advisors | 16k | $29k | -6% | Sep 2025 |
|
| Point72 Asia | 15k | $27k | -50% | Sep 2025 |
|
| Advisor Group Holdings | 12k | $22k | 0% | Sep 2025 |
|
| Prudential Financial | 12k | $21k | 100% | Sep 2025 |
|
| Tower Research Capital | 11k | $20k | -12% | Sep 2025 |
|
| UBS Group | 11k | $20k | -97% | Sep 2025 |
|
| Aries Wealth Management | 10k | $18k | 0% | Sep 2025 |
|
| Waldron | 10k | $18k | 0% | Sep 2025 |
|
| FMR | 10k | $18k | -8% | Sep 2025 |
|
| China Universal Asset Management | 9.2k | $17k | -12% | Sep 2025 |
|
| Federated Investors | 2.2k | $4.0k | 0% | Sep 2025 |
|
| Mirae Asset Global Investments | 2.0k | $3.7k | 0% | Sep 2025 |
|
| Gf Fund Management | 1.0k | $1.9k | -16% | Sep 2025 |
|
| Royal Bank of Canada | 806.00 | $0 | 1068% | Sep 2025 |
|
| NISA Investment Advisors | 593.00 | $1.1k | -19% | Sep 2025 |
|
| Rialto Wealth Management | 381.00 | $693.991500 | 0% | Sep 2025 |
|
| Strategic Wealth Partners | 311.00 | $565.988900 | 0% | Sep 2025 |
|
| SBI Securities | 212.00 | $386.009600 | 0% | Sep 2025 |
|
| Rockefeller Capital Management | 200.00 | $364.000000 | 100% | Sep 2025 |
|
| EverSource Wealth Advisors | 65.00 | $118.001000 | -7% | Sep 2025 |
|
| Atlas Capital Advisors | 18.00 | $25.999200 | 0% | Jun 2025 |
|
| True Wealth Design | 9.00 | $17.000100 | -79% | Sep 2025 |
|
| CWM | 8.00 | $0 | -99% | Sep 2025 |
|
Who sold out of Tscan Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Troluce Capital Advisors | Jun 2025 | 150k | $218k |
| Y-Intercept | Jun 2025 | 77k | $111k |
| Hrt Financial | Jun 2025 | 55k | $80k |
| Jain Global | Jun 2025 | 38k | $55k |
| Boothbay Fund Management | Jun 2025 | 24k | $35k |
| Squarepoint Ops | Jun 2025 | 23k | $33k |
| AQR Capital Management | Jun 2025 | 22k | $33k |
| Charles Schwab Investment Management | Jun 2025 | 22k | $32k |
| Dynamic Technology Lab Private | Jun 2025 | 14k | $20k |
| DRW Holdings | Jun 2025 | 10k | $15k |
| Wells Fargo & Company | Jun 2025 | 323.00 | $467.994700 |